Publikationen (21) Publikationen, an denen Forscher/innen teilgenommen haben

2024

  1. Acetazolamide-induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database

    British Journal of Clinical Pharmacology, Vol. 90, Núm. 7, pp. 1751-1755

  2. Analysis 2016-2021 of the development of the MAPEX outpatient pharmaceutical care Project by regions in Spain

    Farmacia Hospitalaria, Vol. 48, Núm. 2, pp. 64-69

  3. Analysis of the evolution of outpatient pharmaceutical care in hospital pharmacy services in Spain after the implementation and development of the MAPEX initiative

    Journal of Healthcare Quality Research, Vol. 39, Núm. 2, pp. 65-79

  4. Analysis of the situation of pharmaceutical care for patients with immune-mediated inflammatory diseases before and after the COVID-19 pandemic

    Farmacia Hospitalaria

  5. Astrocyte S100β expression and selective differentiation to GFAP and GS in the entorhinal cortex during ageing in the 3xTg-Alzheimer's disease mouse model

    Acta Histochemica, Vol. 126, Núm. 1

  6. Biosimilars and access to biologic therapy in immune-mediated diseases

    Expert Opinion on Biological Therapy, Vol. 24, Núm. 7, pp. 647-653

  7. De-imFAR phase II project: a study protocol for a cluster randomised implementation trial to evaluate the effectiveness of de-implementation strategies to reduce low-value statin prescribing in the primary prevention of cardiovascular disease

    BMJ Open, Vol. 14, Núm. 4

  8. Drug-induced hyponatraemia and possible related signals: Analysis of 659 cases reported to the Spanish Pharmacovigilance System and disproportionality analysis

    Medicina Clinica

  9. Elimination of hepatitis C virus in a prison: An 18-year experience

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 5, pp. 236-241

  10. Evaluation of the safety of medication-use systems in hospital emergency services

    Farmacia Hospitalaria

  11. GEDEFO-SEFH management of antineoplastic extravasations survey results

    Journal of Oncology Pharmacy Practice, Vol. 30, Núm. 1, pp. 67-77

  12. Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta

    Biomedicine and Pharmacotherapy, Vol. 175

  13. Incorporating the One Health philosophy into pharmacovigilanc: Pharmacovigilance

    British Journal of Clinical Pharmacology

  14. Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance

    European Neuropsychopharmacology

  15. Kimioterapiaren ondorengo anemiaren eta sukar-neutropeniaren maneiua

    Osagaiz: osasun-zientzien aldizkaria, Vol. 8, Núm. 1, pp. 101-106

  16. Ospitaleko farmazialariaren eta medikuaren arteko elkarlana GIBa duten pazienteen tratamenduen eraginkortasuna eta segurtasuna bermatzeko

    Osagaiz: osasun-zientzien aldizkaria, Vol. 8, Núm. 1, pp. 51-58

  17. Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain

    BMC Geriatrics, Vol. 24, Núm. 1

  18. Psychometric characteristics of the Spanish version of the HIV Symptom Index

    Journal of patient-reported outcomes, Vol. 8, Núm. 1, pp. 116

  19. Use of rasburicase to improve kidney function in children with hyperuricemia and acute kidney injury

    Clinical and Experimental Nephrology, Vol. 28, Núm. 1, pp. 13-22

  20. [Translated article] Analysis 2016-2021 of the development of the MAPEX outpatient pharmaceutical care Project by Regions in Spain

    Farmacia Hospitalaria, Vol. 48, Núm. 2, pp. T64-T69